Deflectable Catheters Market Report 2024

This Deflectable Catheters market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The deflectable catheters market size has grown strongly in recent years. It will grow from $1.8 billion in 2023 to $1.89 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth during the historic period can be attributed to increased diagnostic imaging needs, a growing geriatric population, higher investments in healthcare innovations, and a rise in outpatient procedures.

The deflectable catheters market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth projected for the forecast period can be attributed to the rising prevalence of chronic diseases, a growing emphasis on minimally invasive techniques, increasing demand for angioplasty, higher hospitalization rates, and the rising incidence of peripheral artery diseases. Key trends during this period include advancements in technology, the development of multi-function devices, the expansion of telemedicine, patient-centric designs, and the miniaturization of devices.

The rising incidence of cardiovascular diseases is projected to drive growth in the deflectable catheters market. Cardiovascular diseases (CVDs) represent a major global health challenge, influenced by factors such as an aging population, unhealthy lifestyle choices, and rapid urbanization. Deflectable catheters play a crucial role in cardiovascular procedures by enabling precise navigation and treatment of heart arrhythmias, performing ablations, and accessing challenging areas within the heart or blood vessels. For instance, an August 2022 study published in the Journal of the American College of Cardiology forecasted increases in all four primary cardiovascular risk factors among the U.S. population from 2025 to 2060. The study projected the largest percentage increase in diabetes at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). Consequently, the increasing incidence of cardiovascular diseases is expected to drive the demand for deflectable catheters.

Leading companies in the deflectable catheter market are concentrating on developing innovative products, such as crossing catheters, to strengthen their market position. Crossing catheters are specialized devices designed to navigate blocked or narrowed blood vessels, often used in procedures such as angioplasty. For example, in May 2023, Bentley InnoMed GmbH, a Germany-based healthcare company, introduced the BeBack crossing catheter in the United States. This catheter is specifically engineered for navigating chronic total occlusions (CTOs) and treating heavily calcified lesions. Available in lengths of 80 cm and 120 cm with sizes of 2.9Fr and 4Fr, the BeBack catheter features a steerable and adjustable nitinol needle for precise crossing and targeted re-entry, along with a radiopaque marker to indicate the direction of the curved needle near the catheter tip. The device supports multiple treatment approaches, including antegrade, retrograde, and crossover techniques for intraluminal and subintimal lesions.

In October 2022, Cordis Corporation, a US-based medical device company, acquired MedAlliance for an undisclosed amount. This acquisition is expected to enhance Cordis' technological capabilities and reinforce its leadership in the field of interventional cardiovascular therapies. MedAlliance, a Switzerland-based medical technology company, specializes in advanced drug-device combination products designed for the treatment of coronary and peripheral artery diseases.

Major companies operating in the deflectable catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical, Teleflex Incorporated, Biotronik, Smiths Medical, Merit Medical Systems, Biomerics, Asahi Intecc Co. Ltd., Atricure Inc., AngioDynamics, Oscor Inc., Baylis Medical Company Inc., Vascular Solutions Inc., EndoMed Systems GmbH, BioSig Technologies.

North America was the largest region in the deflectable catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deflectable catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the deflectable catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Deflectable catheters are specialized medical tools equipped with a flexible, steerable tip that can be directed in various directions. This flexibility enables precise navigation through intricate or curved anatomical pathways, such as blood vessels or the heart, during diagnostic or interventional procedures.

The primary types of deflectable catheters are uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Uni-directional deflectable catheters can bend in one direction, offering control and accuracy for reaching specific areas during medical procedures. These catheters are used in applications such as coronary interventions, electrophysiology, diagnostic imaging, and peripheral interventions.

The deflectable catheters market research report is one of a series of new reports that provides deflectable catheters market statistics, including deflectable catheters industry global market size, regional shares, competitors with a deflectable catheters market share, detailed deflectable catheters market segments, market trends and opportunities, and any further data you may need to thrive in the deflectable catheters industry. This deflectable catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deflectable catheters market consists of sales of deflectable microcatheters, steerable guiding sheaths, and steerable electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.